Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women - Manchanda, R; Patel, S; Gordeev, V S (J Natl Cancer Inst, 2018)